Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Five Prime Thera (NQ: FPRX )

22.23 USD -0.85 (-3.68%)
Official Closing Price Updated: 5:11 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Five Prime Thera

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SNSE FDA MNKKQ
From Benzinga
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NVCR CLBS AFIB
From Benzinga
We Did The Math PBE Can Go To $82
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ZYME SWAV NK
From Benzinga
First Week of January 15th Options Trading For Five Prime Therapeutics (FPRX)
Investors in Five Prime Therapeutics, Inc (FPRX) saw new options become available this week, for the January 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
The Week Ahead In Biotech (Jan. 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
After ending 2020 in the green, biotech stocks had a strong start to 2021, partly capitalizing on the broader strength markets saw this past week despite political turmoil at Capitol Hill. The week... 
Tags Stocks / Equities Pharma/Biotech Healthcare
From Blogs - TalkMarkets
The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
JPMorgan Chase & Co. CEO Jamie Dimon is to be among the keynote speakers at next week'sJ.P. Morgan Healthcare ... 
Tags ZYME Biotech VIRI
From Benzinga
Why Five Prime Therapeutics Stock Gained 312% in November
This tiny biotech might be developing a major new cancer drug. 
Tags Market News FPRX
From Motley Fool
These Were the 5 Best Cancer Stocks Of 2020
Biotech investors had more than just vaccines to think about this year. 
Tags CRDF Market News SURF
From Motley Fool
Sum Up The Pieces: PJP Could Be Worth $81
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Have $1,000? Here Are 3 Top Healthcare Stocks to Buy in December
There are plenty of healthcare stocks that have seen share growth this year. Here are three lesser-known stocks that have the potential to continue that growth this month and beyond. 
Tags BMY WST FPRX
From Motley Fool
2 Biotech Stocks That Could Double Your Money
Aptose Biosciences and Five Prime Therapeutics both have explosive growth potential. 
Tags FPRX APTO Market News
From Motley Fool
TalkMarkets Tuesday Talk: Flying High Where The Geese Soar
Amidst the raging pandemic and President Trump’s so far, steadfast reluctance to concede the election to Joe Biden, the stock market continues to fly high seemingly reaching the altitudes of migrating... 
Tags Stocks / Equities Technology Pharma/Biotech
From Blogs - TalkMarkets
A Month for the Ages
Just when you think you’ve seen it all from this market, a month like November comes around. 
From Blogs - TalkMarkets
When To Follow Trend
Last week was a big one for the market thanks to some critical news from Pfizer Inc. (NYSE: PFE) in the company’s phase 3 COVID-19 ... 
Tags General EDRY APVO
From Benzinga
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
Biotech stocks advanced in the week ended November 13 amid a vaccine news flow-induced rally that also lifted the broader market. The week started with positive tidings from Pfizer Inc. and its German... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
Biotech stocks advanced in the week ended Nov. 13 amid a vaccine news flow-induced rally that also lifted the broader market. The ... 
Tags JAGX EIGR Biotech
From Benzinga
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AMGN Biotech EIGR
From Benzinga
65 Biggest Movers From Yesterday
Gainers IMAC Holdings, Inc. (NASDAQ: IMAC) shares climbed 83.3% to close at $1.52 on Thursday after the company reported the ... 
Tags RVLV SMMT VXRT
From Benzinga
12 Healthcare Stocks Moving In Thursday's Intraday Session
Gainers IMAC Holdings (NASDAQ:IMAC) stock moved upwards by 87.41% to $1.55 during Thursday's regular session. The ... 
Tags Benzinga AKER FPRX
From Benzinga
Mid-Day Market Update: Nasdaq Turns Lower; EuroDry Shares Jump After Q3 Results
Midway through trading Thursday, the Dow traded down 0.53% to 29,241.99 while the NASDAQ fell 0.19% to 11,763.76. The S&P also fell, ... 
Tags Eurozone Commodities Earnings
From Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
Gainers IMAC Holdings, Inc. (NASDAQ: IMAC) shares jumped 97.9% to $1.64 after the company reported the purchase of Lockwood ... 
Tags JE SNDL FOSL
From Benzinga
Why Five Prime Therapeutics Stock Is Trading Higher Today
Five Prime Therapeutics (NASDAQ: FPRX) shares were trading higher on Thursday after the company presented first preclinical data on ... 
Tags Market News Small Cap FPRX
From Benzinga
Small Biotech Five Prime Launches For A Second Day Running — Here's Why
Five Prime Therapeutics stock popped for a second day running Thursday after the small biotech company unveiled promising preclinical data for an experimental cancer treatment. 
From Investor's Business Daily
Mid-Morning Market Update: Markets Mixed; TransDigm Earnings Top Estimates
Following the market opening Thursday, the Dow traded down 0.30% to 29,308.49 while the NASDAQ rose 0.44% to 11,838.28. The S&P also ... 
Tags EDRY Earnings INM
From Benzinga
12 Healthcare Stocks Moving In Thursday's Pre-Market Session
Gainers IMAC Holdings (NASDAQ:IMAC) shares rose 107.4% to $1.72 during Thursday's pre-market session. The market ... 
Tags Market News healthcare stocks Markets
From Benzinga
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags QLGN Biotech THMO
From Benzinga
35 Stocks Moving in Thursday's Pre-Market Session
Gainers EuroDry Ltd. (NASDAQ: EDRY) rose 133.9% to $10.50 in pre-market trading after the company swung to a profit in the third ... 
Tags SPTN FTEK Markets
From Benzinga
56 Biggest Movers From Yesterday
Gainers Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares surged 237.1% to close at $18.00 on Wednesday in reaction to a ... 
Tags ALTM Trading Ideas INN
From Benzinga
Are These The Best Biotech Stocks To Watch In November 2020?
From Stockmarket.com
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.